Price Alert

Diffusion Pharmaceuticals... (DFFN)

NASDAQ: DFFN · Real-Time Price · USD

4.40

0.41 (10.28%)

At close: Aug 16, 2023, 10:00 PM

Diffusion Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	10.5M	9M	7.74M	10.01M	10.42M	15M	14.65M	10.11M	6.59M	5.97M	9.87M	37.31M	40.34M	43.31M	46.63M
Short-Term Investments	24.74M	29.92M	38.91M	35.08M	n/a	n/a	2.99M	12.41M	19.27M	22.57M	22.68M	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	2.99B	n/a	n/a	n/a	n/a	n/a	n/a	-443.89K	-443.89K
Other Long-Term Assets	n/a	n/a	73.94K	5.86M	194.44K	n/a	-2.99B	n/a	n/a	n/a	n/a	15.58K	15.58K	-428.31K	-428.31K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	3.33M	4.16M	2.15M	2.24M	1.42M	695.07K	767.53K	112.41K	464.88K	643.62K	1.02M	510.01K	380.1K	552.09K	678.69K
Total Current Assets	38.58M	43.08M	48.81M	47.33M	11.84M	15.69M	18.4M	22.64M	26.32M	29.18M	33.57M	37.82M	40.72M	43.86M	47.31M
Property-Plant & Equipment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	149.78K	196.82K	244.86K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	8.64M	8.64M
Total Long-Term Assets	n/a	n/a	73.94K	5.86M	194.44K	n/a	2.99B	n/a	n/a	n/a	n/a	15.58K	165.36K	8.85M	8.9M
Total Assets	38.58M	43.08M	48.88M	53.19M	12.04M	15.69M	18.4M	22.64M	26.32M	29.18M	33.57M	37.84M	40.88M	52.71M	56.21M
Account Payables	1.86M	1.51M	1.08M	725.85K	533.79K	932.43K	971.46K	1.13M	807.37K	846.03K	813.2K	947.5K	678.04K	749.95K	952.91K
Deferred Revenue	n/a	n/a	n/a	1.4M	547.05K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	67.89K	95.83K	111.29K
Other Current Liabilities	n/a	n/a	n/a	n/a	n/a	532.55K	1.15M	n/a	1.46M	1.67M	2.14M	1.98M	2M	1.25M	1.05M
Total Current Liabilities	1.86M	1.51M	1.08M	2.13M	1.08M	1.46M	2.13M	2.42M	2.27M	2.52M	2.96M	2.93M	2.75M	2.1M	2.11M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	8.82K
Other Long-Term Liabilities	2.08M	2.37M	2.16M	1.09M	1.38M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	2.08M	2.37M	2.16M	1.09M	1.38M	532.55M	n/a	1.29M	807.37K	n/a	n/a	n/a	n/a	443.89K	452.71K
Total Liabilities	3.94M	3.88M	3.25M	3.21M	2.46M	1.46M	2.13M	2.42M	2.27M	2.52M	2.96M	2.93M	2.75M	2.54M	2.57M
Total Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	67.89K	95.83K	120.11K
Common Stock	8.7K	8.7K	8.25K	8.25K	5.67K	2.04K	2.04K	2.04K	2.04K	2.04K	2.04K	101.91K	101.9K	101.9K	101.9K
Retained Earnings	-75.63M	-70.73M	-64.03M	-59.27M	-52.08M	-151.8M	-149.69M	-145.6M	-141.52M	-138.72M	-134.53M	-130.01M	-126.53M	-114.33M	-110.55M
Comprehensive Income	21.22K	56.2K	123.16K	-19.7K	-12.04M	n/a	-3.12K	-35.38K	-86.95K	-86.58K	-49.66K	n/a	n/a	n/a	n/a
Shareholders Equity	34.63M	39.2M	45.64M	49.98M	9.57M	14.23M	16.28M	20.22M	24.05M	26.67M	30.62M	34.91M	38.13M	50.17M	53.65M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	2.99B	12.41M	19.27M	22.57M	22.68M	n/a	n/a	n/a	n/a